Dementia Care Conference 2024

Join us for an educational session with nationally recognized Dr. Lycia Neumann as she goes over the latest breakthroughs in drugs and treatments for dementia. Gain insights into newly announced medications and therapeutic approaches, as Dr. Neumann demystifies their potential impact on enhancing the quality of life for individuals affected by dementia.

Engage with our expert panel as they delve into the transformative effects of alternative therapies and discover firsthand accounts of how these innovative approaches have positively impacted local families coping with dementia.

Expo of 40+ sponsors and vendors that support both caregivers and individuals living with Alzheimer’s disease or other forms of dementia.

Breakfast and lunch will be provided with registration. Agenda and supplemental information to be shared at a closer date.

Early Bird tickets are available now for a discounted price of $65!

Early Bird pricing is available until April 1, 2024.

LYCIA TRAMUJAS VASCONCELLOS NEUMANN, PH.D, MPA

As senior director, Health Services Research, Dr. Neumann plays a pivotal role in advancing research that informs evidence-based policies and practices for timely, quality, cost-effective and equitable person-centered dementia care.

Before joining the Alzheimer’s Association, Dr. Neumann held roles at Highmark Wholecare, a Medicaid and Medicare managed care organization based in Pittsburgh, and Instituto Oncoguia, a Brazilian cancer patient advocacy organization. With more than 25 years of experience, she has planned, managed and evaluated health and social programs, leading to numerous publications about citizen-driven community development, evaluation of public policies and programs, aging and population health.

A member of the Gerontological Society of America (GSA) and the American Evaluation Association (AEA), Dr. Neumann is committed to helping organizations be more effective by using research and evaluation to inform decision-making and by establishing purposeful partnerships to strengthen the impact of their work. Her interests lie in health care policy and programs, global health, health disparities, caregiving and aging, both as an applied researcher and evaluator.

She serves on the editorial board of Innovation in Aging, a scientific journal of the Gerontological Society of America, on the Advisory Council of the Allegheny County Area Agency on Aging and on the board of directors of Jeremiah’s Place, a crisis nursery.

Dr. Neumann completed her Ph.D. in behavior and community health sciences from the School of Public Health at the University of Pittsburgh. She also earned graduate certificates in the Evaluation of Public Health Programs and Latin America Social and Public Policy. Dr. Neumann holds a master’s degree in public administration from Dalhousie University in Halifax, Canada, and two bachelor’s degrees in business administration and social communications.

The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. For more information, visit alz.org.